Toll like receptor agonist effects on human CD8+ T cell activation and expression of T cell checkpoint receptors
Donghwan Jeon, Jena E Moseman, Ethan Hill, Douglas G McNeel · 2025
Read Toll like receptor agonist effects on human CD8+ T cell activation and expression of T cell checkpoint receptors by Donghwan Jeon, Jena E Moseman, Ethan Hill, Douglas G McNeel (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12716034.txt.
Description
Donghwan Jeon, Jena Moseman, Ethan Hill, and Douglas McNeel test immune-boosting drugs on human killer T cells, in a 2025 study. Earlier mouse work suggested that drugs waking up toll-like receptors could keep these cells from raising brake proteins that slow them down. The team checked whether the same holds in people.
They used stored blood from donors whose T cells react to two common viruses. Adding the receptor drugs did not grow more virus-specific cells or change brake protein levels much. One drug, aimed at a third receptor type, did help when paired with feeder cells that present the virus: more T cells fired their main attack signal. The results narrow which immune boosters deserve a place beside cancer vaccines.
Catalog record
| CREATOR | Donghwan Jeon, Jena E Moseman, Ethan Hill, Douglas G McNeel |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |